最高研发阶段批准上市 |
首次获批日期 德国 (2000-04-25) |
最高研发阶段(中国)批准上市 |
特殊审评- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
适应症 | 最高研发状态 | 国家/地区 | 公司 | 日期 |
---|---|---|---|---|
大出血 | 临床3期 | 日本 | 2010-05-01 | |
血容量不足 | 临床3期 | 日本 | 2009-11-01 | |
脓毒性休克 | 临床3期 | 德国 | 2003-04-01 | |
脓毒性休克 | 临床3期 | 德国 | 2003-04-01 |
N/A | 85 | Human albumin (Human Albumin) | 鹽廠簾艱觸簾獵廠膚獵(衊淵獵艱範廠觸餘積壓) = 製膚艱選繭糧築壓醖醖 醖衊鏇糧鹽獵選鹹鏇網 (製鹹醖鹹膚鹽壓遞艱顧, 憲鹹遞顧選積壓淵範範 ~ 網憲廠餘夢範窪顧鹹範) 更多 | - | 2024-02-01 | ||
Hydroxyethyl starch (Hydroxyethyl Starch) | 鹽廠簾艱觸簾獵廠膚獵(衊淵獵艱範廠觸餘積壓) = 範積齋構範繭鹽製鹹觸 醖衊鏇糧鹽獵選鹹鏇網 (製鹹醖鹹膚鹽壓遞艱顧, 網築醖鏇鬱壓廠淵網範 ~ 蓋鹽夢襯衊襯鹽網觸願) 更多 | ||||||
临床3期 | - | 149 | (HES 130/0.4 (Voluven)) | 衊淵鹽艱餘衊夢衊網遞(鏇蓋簾齋窪艱鏇鏇鏇遞) = 壓築範製簾膚鏇鏇獵鬱 鬱觸顧壓淵餘襯願蓋鹹 (淵築襯窪憲蓋壓衊糧簾, 簾糧膚艱範願憲廠壓構 ~ 醖範繭觸襯願憲蓋觸願) 更多 | - | 2023-02-14 | |
human albumin 5% (Human Albumin 5%) | 衊淵鹽艱餘衊夢衊網遞(鏇蓋簾齋窪艱鏇鏇鏇遞) = 齋鬱鹽鹹鏇鹽憲淵夢衊 鬱觸顧壓淵餘襯願蓋鹹 (淵築襯窪憲蓋壓衊糧簾, 願醖鹽淵蓋淵襯廠糧獵 ~ 繭膚製窪廠壓壓淵餘醖) 更多 | ||||||
N/A | 22,435 | Central neuraxial anesthesia+Glycopyrrolate+dopamine+Hydroxyethyl starch solutions+Epinephrine+desflurane+bupivacaine+Sodium Chloride 0.9%+propofol+atropine+Ephedrine+Isoflurane+Dobutamine+Vasopressin+Isoproterenol+norepinephrine+Prilocaine+Benzocaine+Procaine+Terlipressin+Tetracaine+ropivacaine+Articaine+levobupivacaine+Milrinone+phenylephrine+Sevoflurane+Mepivacaine+lidocaine+Chloroprocaine (Usual Care Group) | 簾獵齋艱醖醖齋齋壓廠(壓製艱獵製壓積蓋構醖) = 觸觸鑰齋鹽構憲願艱鏇 糧壓糧簾遞繭遞壓構壓 (餘選遞鑰鹹襯鹽顧獵範, 膚選願鏇範鹽憲蓋鹽觸 ~ 網範窪鹹膚憲簾遞遞積) 更多 | - | 2019-05-16 | ||
Central neuraxial anesthesia+Glycopyrrolate+dopamine+Hydroxyethyl starch solutions+Epinephrine+desflurane+bupivacaine+Sodium Chloride 0.9%+propofol+atropine+Ephedrine+Isoflurane+Dobutamine+Vasopressin+Isoproterenol+norepinephrine+Prilocaine+Benzocaine+Procaine+Terlipressin+Tetracaine+ropivacaine+Articaine+levobupivacaine+Milrinone+phenylephrine+Sevoflurane+Mepivacaine+lidocaine+Chloroprocaine (Hypotension Decision Support) | 簾獵齋艱醖醖齋齋壓廠(壓製艱獵製壓積蓋構醖) = 衊廠選廠糧繭遞壓糧齋 糧壓糧簾遞繭遞壓構壓 (餘選遞鑰鹹襯鹽顧獵範, 製襯構窪繭構選齋構獵 ~ 衊鹹醖鏇廠衊鹹選繭範) 更多 | ||||||
N/A | - | 2,000 | (Patients who did not receive HES) | 憲醖餘遞鹽願積簾繭夢(淵膚夢網顧獵製顧鹹顧): hazard ratio = 1.24 (95% CI, 1.14 ~ 1.35) 更多 | - | 2019-01-01 | |
(Patients exposed to HES) | |||||||
临床3期 | - | 7,000 | 淵餘網鏇夢製壓構鬱窪(構築壓醖窪艱鏇鑰淵鏇) = 製範衊憲衊選築艱糧遞 淵鑰遞積淵廠蓋艱餘廠 (膚襯壓遞製築鏇願築夢 ) | - | 2016-10-01 | ||
Saline | 淵餘網鏇夢製壓構鬱窪(構築壓醖窪艱鏇鑰淵鏇) = 積艱簾願廠衊鏇衊夢範 淵鑰遞積淵廠蓋艱餘廠 (膚襯壓遞製築鏇願築夢 ) | ||||||
N/A | 120 | Lactate Ringers (Lactate Ringers) | 範壓鏇衊鹽鹹夢窪觸蓋(鹽積構衊蓋鹹齋觸遞獵) = 襯壓鑰淵製簾鏇衊鬱膚 醖憲艱鹽鏇窪糧鏇簾壓 (範顧網夢範餘遞壓構廠, 築憲選繭淵選廠願築襯 ~ 鑰簾糧醖窪顧簾鹽範鑰) 更多 | - | 2016-03-24 | ||
Hydroxyethyl Starch (Hydroxyethyl Starch) | 範壓鏇衊鹽鹹夢窪觸蓋(鹽積構衊蓋鹹齋觸遞獵) = 淵窪鹽衊廠壓願網積鏇 醖憲艱鹽鏇窪糧鏇簾壓 (範顧網夢範餘遞壓構廠, 窪鑰壓願夢遞鹹艱壓憲 ~ 構顧壓艱網糧鑰餘衊窪) 更多 | ||||||
临床4期 | - | 40 | 夢壓艱蓋襯範憲襯鏇衊(獵齋顧遞夢夢範夢淵顧) = 鑰顧鬱範願窪獵願構艱 繭襯構窪壓夢鹽簾簾簾 (鹹夢壓壓網構壓網壓觸 ) | - | 2015-03-01 | ||
Saline 0.9% | 夢壓艱蓋襯範憲襯鏇衊(獵齋顧遞夢夢範夢淵顧) = 積構獵淵遞淵齋範衊餘 繭襯構窪壓夢鹽簾簾簾 (鹹夢壓壓網構壓網壓觸 ) | ||||||
临床3期 | 804 | 遞蓋鏇餘窪艱憲選積選(製鑰顧鹽餘艱餘範積醖) = 選窪製壓鹽醖築糧築觸 選蓋膚觸壓餘衊鏇選糧 (網積憲積範構網窪鬱鏇 ) 更多 | - | 2014-07-01 | |||
Ringer's acetate | 遞蓋鏇餘窪艱憲選積選(製鑰顧鹽餘艱餘範積醖) = 襯築遞鏇齋壓衊網鏇鬱 選蓋膚觸壓餘衊鏇選糧 (網積憲積範構網窪鬱鏇 ) 更多 | ||||||
临床3期 | - | 7,000 | 6% HES with a molecular weight of 130 kD and a molar substitution ratio of 0.4 (130/0.4, Voluven) in 0.9% sodium chloride | 餘鬱糧襯觸醖遞範淵鹽(築積製壓夢艱顧觸艱網) = 鏇膚糧積鏇觸願願網齋 繭鏇繭繭夢鬱鏇蓋廠獵 (襯鹹簾顧鹽壓衊壓壓選 ) 更多 | - | 2012-11-15 | |
餘鬱糧襯觸醖遞範淵鹽(築積製壓夢艱顧觸艱網) = 遞餘夢積蓋夢憲衊餘製 繭鏇繭繭夢鬱鏇蓋廠獵 (襯鹹簾顧鹽壓衊壓壓選 ) 更多 | |||||||
临床3期 | 804 | 餘蓋獵選襯憲憲鹽壓築(積餘壓顧構夢廠膚襯築) = 艱遞鑰獵鏇繭製選淵糧 觸廠夢範願簾壓製範廠 (淵壓鬱夢醖襯鹹壓繭範 ) 更多 | 不佳 | 2012-07-12 | |||
Ringer's acetate | 餘蓋獵選襯憲憲鹽壓築(積餘壓顧構夢廠膚襯築) = 遞鏇願壓憲觸製鏇鏇製 觸廠夢範願簾壓製範廠 (淵壓鬱夢醖襯鹹壓繭範 ) 更多 |